Table: Stella Pharma -2025/26 parent forecast

Stella Pharma

14/10/2025 06:00

Oct 14 (Reuters) -
              Stella Pharma Corporation     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2026      Mar 31, 2026   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           377 mln            1.01       
  Operating    loss 922 mln      loss 348 mln   
  Recurring    loss 908 mln      loss 345 mln   
  Net          loss 911 mln      loss 348 mln   
  EPS         loss 26.08 yen    loss 10.23 yen  
 
  NOTE - Stella Pharma Corporation.    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T